Effect of oxygen limitation on the in vitro activity of levofloxacin and other antibiotics administered by the aerosol route against Pseudomonas aeruginosa from cystic fibrosis patients

Diagnostic Microbiology and Infectious Disease

Volumn 66, Issue 2, 2010, Pages 181-186

  King, Paula ^a   Citron, Diane M ^b   Griffith, David C ^a   Lomovskaya, Olga ^a   Dudley, Michael N ^a  

^a Mpex Pharmaceuticals Inc   (United States)

^b R M ALDEN RESEARCH LABORATORY   (United States)

Author keywords

Anaerobic; Antimicrobial susceptibility testing; Cystic fibrosis; Levofloxacin; MIC; Pseudomonas aeruginosa

Indexed keywords

AMIKACIN; AZTREONAM; LEVOFLOXACIN; OXYGEN; POTASSIUM NITRATE; TOBRAMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; CONTROLLED STUDY; CYSTIC FIBROSIS; GENE OVEREXPRESSION; HUMAN; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MUTATION; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SPUTUM ANALYSIS;

AEROBIOSIS; AEROSOLS; ANAEROBIOSIS; ANTI-BACTERIAL AGENTS; CYSTIC FIBROSIS; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; OFLOXACIN; OXYGEN; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; TIME FACTORS;

EID: 73749084328     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2009.09.009     Document Type: Article

References (22)

1. Aaron S.D., Ramotar K., Ferris W., Vandemheen K., Saginur R., Tullis E., Haase D., Kottachchi D., St Denis M., and Chan F. Adult cystic fibrosis exacerbations and new strains of Pseudomonas aeruginosa. Am. J. Respir. Crit. Care. Med. 169 (2004) 811-815
2. Borriello G., Richards L., Ehrlich G.D., and Stewart P.S. Arginine or nitrate enhances antibiotic susceptibility of Pseudomonas aeruginosa in biofilms. Antimicrob. Agents Chemother. 50 (2006) 382-384
3. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard-seventh edition, M7-A7 (2006), CLSI, Wayne, PA
4. Cooper M.A., Andrews J.M., and Wise R. Bactericidal activity of sparfloxacin and ciprofloxacin under anaerobic conditions. J. Antimicrob. Chemother. 28 (1991) 399-405
5. Cystic Fibrosis Foundation. Patient registry 2006 annual report (2007) Bethesda, MD: Cystic Fibrosis Foundation
6. Field T.R., White A., Elborn J.S., and Tunney M.M. Effect of oxygen limitation on the in vitro antimicrobial susceptibility of clinical isolates of Pseudomonas aeruginosa grown planktonically and as biofilms. Eur. J. Clin. Microbiol. Infect. Dis. 24 (2005) 677-687
7. Geller D.E., Flume P., Schwab R., Fomos P., Conrad D., Morgan E., Griffith D., Lomovskaya O., Loutit J., and Dudley M.N. A phase I safety, tolerability and pharmacokinetic (PK) study of MP-376 (levofloxacin inhalation solution) in stable cystic fibrosis (CF) patients. Pediatr. Pulmonol. 43 Supp. (2008) S31
8. Grasemann H., Ioannidis I., Tomkiewicz R.P., de Groot H., Rubin B.K., and Ratjen F. Nitric oxide metabolites in cystic fibrosis lung disease. Arch. Dis. Child. 78 (1998) 49-53
9. Hill D., Rose B., Pajkos A., Robinson M., Bye P., Bell S., Elkins M., Thompson B., Macleod C., Aaron S.D., and Harbour C. Antibiotic susceptibilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions. J. Clin. Microbiol. 43 (2005) 5085-5090
10. Karpati F., and Jonasson J. Polymerase chain reaction for the detection of Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Burkholderia cepacia in sputum of patients with cystic fibrosis. Mol. Cell. Probes. 10 (1996) 397-403
11. Lewin C.S., Morrissey I., and Smith J.T. The bactericidal activity of sparfloxacin. J. Antimicrob. Chemother. 30 (1992) 625-632
12. Lomovskaya O., Lee A., Hoshino K., Ishida H., Mistry A., Warren M.S., Boyer E., Chamberland S., and Lee V.J. Use of a genetic approach to evaluate the consequences of inhibition of efflux pumps in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 43 (1999) 1340-1346
13. Mesaros N., Nordmann P., Plesiat P., Roussel-Delvallez M., Van Eldere J., Glupczynski Y., Van Laethem Y., Jacobs F., Lebecque P., Malfroot A., Tulkens P.M., and Van Bambeke F. Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium. Clin. Microbiol. Infect. 13 (2007) 560-578
14. Morrissey I., and Smith J.T. Absence of bactericidal activity of sparfloxacin and ciprofloxacin under anaerobic conditions. J. Antimicrob. Chemother. 29 (1992) 589-590
15. Palmer K.L., Brown S.A., and Whiteley M. Membrane-bound nitrate reductase is required for anaerobic growth in cystic fibrosis sputum. J. Bacteriol. 189 (2007) 4449-4455
16. Saiman L., and Siegel J. Infection control in cystic fibrosis. Clin. Microbiol. Rev. 17 (2004) 57-71
17. Shawar R.M., MacLeod D.L., Garber R.L., Burns J.L., Stapp J.R., Clausen C.R., and Tanaka S.K. Activities of tobramycin and six other antibiotics against Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Antimicrob. Agents Chemother. 43 (1999) 2877-2880
18. Valenza G., Tappe D., Turnwald D., Frosch M., Konig C., Hebestreit H., and Abele-Horn M. Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis. J. Cyst. Fibros. 7 (2008) 123-127
19. Vander Wauven C., Pierard A., Kley-Raymann M., and Haas D. Pseudomonas aeruginosa mutants affected in anaerobic growth on arginine: evidence for a four-gene cluster encoding the arginine deiminase pathway. J. Bacteriol. 160 (1984) 928-934
20. Worlitzsch D., Tarran R., Ulrich M., Schwab U., Cekici A., Meyer K.C., Birrer P., Bellon G., Berger J., Weiss T., Botzenhart K., Yankaskas J.R., Randell S., Boucher R.C., and Doring G. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J. Clin. Invest. 109 (2002) 317-325
21. Zabinski R.A., Walker K.J., Larsson A.J., Moody J.A., Kaatz G.W., and Rotschafer J.C. Effect of aerobic and anaerobic environments on antistaphylococcal activities of five fluoroquinolones. Antimicrob. Agents Chemother. 39 (1995) 507-512
22. Zumft W.G. Cell biology and molecular basis of denitrification. Microbiol. Mol. Biol. Rev. 61 (1997) 533-616